- Home
- LPG vs WGS Comparison
LPG vs WGS Comparison
Compare LPG & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPG | WGS |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | 1300 |
| Industry | Marine Transportation | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | LPG | WGS |
|---|---|---|
| Price | $41.89 | $65.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $39.33 | ★ $120.71 |
| AVG Volume (30 Days) | 791.4K | ★ 829.7K |
| Earning Date | 05-21-2026 | 05-04-2026 |
| Dividend Yield | ★ 8.26% | N/A |
| EPS Growth | ★ 112.15 | N/A |
| EPS | ★ 4.54 | N/A |
| Revenue | ★ $481,511,242.00 | N/A |
| Revenue This Year | $35.73 | $29.98 |
| Revenue Next Year | N/A | $25.92 |
| P/E Ratio | ★ $9.13 | $1,251.58 |
| Revenue Growth | ★ 36.27 | N/A |
| 52 Week Low | $23.76 | $32.21 |
| 52 Week High | $48.12 | $170.87 |
Technical Indicators
Market Signals| Indicator | LPG | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 58.15 | 53.59 |
| Support Level | $39.82 | $55.76 |
| Resistance Level | $45.23 | $73.21 |
| Average True Range (ATR) | 1.79 | 4.13 |
| MACD | 0.57 | -0.79 |
| Stochastic Oscillator | 98.27 | 39.81 |
Price Performance
Historical ComparisonAbout LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.